Vinodkumar Gandalal Shah's Insider Trades & SAST Disclosures
Vinodkumar Gandalal Shah's most recent trade in Remus Pharmaceuticals Ltd. was a Buy of 50 Equity Shares done at an average price of Rs. 2403.6 . Disclosure was reported to the exchange on Jan. 10, 2025 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
Vinodkumar Gandalal Shah's has made SAST transactions in Remus Pharmaceuticals Ltd. recently where a Acquisition of 50 Equity shares done . Disclosure was reported to the exchange on Jan. 9, 2025.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Remus Pharma | Vinodkumar Gandalal Shah | Promoter | Acquisition | 16 Jan 2025 | 50 | 3,050 | - | - | 30 Dec 2024 30 Dec 2024 |
SAST (Reg29(2)) | Equity shares | Open Market | |
| Remus Pharma | Vinodkumar Gandalal Shah | Promoter | Sale | 16 Jan 2025 | 50 | 3,000 | - | - | 03 Jan 2025 03 Jan 2025 |
SAST (Reg29(2)) | Equity shares | Open Market | |
| Remus Pharma | Vinodkumar Gandalal Shah | Promoter | Acquisition | 16 Jan 2025 | 100 | 3,100 | - | - | 06 Jan 2025 06 Jan 2025 |
SAST (Reg29(2)) | Equity shares | Open Market | |
| Remus Pharma | Vinodkumar Gandalal Shah | Promoter | Acquisition | 16 Jan 2025 | 50 | 3,150 | - | - | 07 Jan 2025 07 Jan 2025 |
SAST (Reg29(2)) | Equity shares | Open Market | |
| Remus Pharma | Vinodkumar Gandalal Shah | Promoter Group | Buy | 10 Jan 2025 | 50 | 3,050 | - | 2403.6 | 120,178 | 30 Dec 2024 30 Dec 2024 |
Insider Trading (-) | Equity Shares | Market Purchase |
| Remus Pharma | Vinodkumar Gandalal Shah | Promoter Group | Sell | 10 Jan 2025 | 50 | 3,000 | - | 2525 | 126,250 | 03 Jan 2025 03 Jan 2025 |
Insider Trading (-) | Equity Shares | Market Sale |
| Remus Pharma | Vinodkumar Gandalal Shah | Promoter Group | Buy | 10 Jan 2025 | 50 | 3,100 | - | 2425 | 121,250 | 06 Jan 2025 06 Jan 2025 |
Insider Trading (-) | Equity Shares | Market Purchase |
| Remus Pharma | Vinodkumar Gandalal Shah | Promoter Group | Buy | 10 Jan 2025 | 50 | 3,050 | - | 2385 | 119,250 | 06 Jan 2025 06 Jan 2025 |
Insider Trading (-) | Equity Shares | Market Purchase |
| Remus Pharma | Vinodkumar Gandalal Shah | Promoter Group | Buy | 10 Jan 2025 | 50 | 3,150 | - | 2345 | 117,250 | 07 Jan 2025 07 Jan 2025 |
Insider Trading (-) | Equity Shares | Market Purchase |
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.